Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,884 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.
Bill M, Grimm J, Jentzsch M, Kloss L, Goldmann K, Schulz J, Beinicke S, Häntschel J, Cross M, Vucinic V, Pönisch W, Behre G, Franke GN, Lange T, Niederwieser D, Schwind S. Bill M, et al. Among authors: schulz j. Ann Hematol. 2018 Oct;97(10):1757-1765. doi: 10.1007/s00277-018-3373-y. Epub 2018 May 22. Ann Hematol. 2018. PMID: 29785446
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation.
Grimm J, Bill M, Jentzsch M, Beinicke S, Häntschel J, Goldmann K, Schulz J, Cross M, Franke GN, Behre G, Vucinic V, Pönisch W, Lange T, Niederwieser D, Schwind S. Grimm J, et al. Among authors: schulz j. Bone Marrow Transplant. 2019 Aug;54(8):1189-1197. doi: 10.1038/s41409-018-0413-0. Epub 2018 Nov 30. Bone Marrow Transplant. 2019. PMID: 30504903
Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia.
Jentzsch M, Bill M, Grimm J, Schulz J, Beinicke S, Häntschel J, Goldmann K, Pönisch W, Franke GN, Vucinic V, Cross M, Behre G, Lange T, Niederwieser D, Schwind S. Jentzsch M, et al. Among authors: schulz j. Hemasphere. 2019 Feb 8;3(1):e167. doi: 10.1097/HS9.0000000000000167. eCollection 2019 Feb. Hemasphere. 2019. PMID: 31723806 Free PMC article.
High expression of the stem cell marker GPR56 at diagnosis identifies acute myeloid leukemia patients at higher relapse risk after allogeneic stem cell transplantation in context with the CD34+/CD38- population.
Jentzsch M, Bill M, Grimm J, Schulz J, Schuhmann L, Brauer D, Goldmann K, Wilke F, Franke GN, Behre G, Pönisch W, Vucinic V, Niederwieser D, Platzbecker U, Schwind S. Jentzsch M, et al. Among authors: schulz j. Haematologica. 2020 Oct 1;105(10):e507. doi: 10.3324/haematol.2019.229260. Haematologica. 2020. PMID: 33054093 Free PMC article. No abstract available.
ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation.
Jentzsch M, Grimm J, Bill M, Brauer D, Backhaus D, Goldmann K, Schulz J, Niederwieser D, Platzbecker U, Schwind S. Jentzsch M, et al. Among authors: schulz j. Bone Marrow Transplant. 2021 Apr;56(4):936-945. doi: 10.1038/s41409-020-01129-1. Epub 2020 Nov 19. Bone Marrow Transplant. 2021. PMID: 33208914 Free PMC article.
Clinical value of the measurable residual disease status within the ELN2017 risk groups in AML patients undergoing allogeneic stem cell transplantation.
Jentzsch M, Grimm J, Bill M, Brauer D, Backhaus D, Pointner R, Goldmann K, Schulz J, Niederwieser D, Platzbecker U, Schwind S. Jentzsch M, et al. Among authors: schulz j. Am J Hematol. 2021 Jul 1;96(7):E237-E239. doi: 10.1002/ajh.26179. Epub 2021 May 5. Am J Hematol. 2021. PMID: 33811773 Free article. No abstract available.
Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation.
Jentzsch M, Grimm J, Bill M, Brauer D, Backhaus D, Schulz J, Goldmann K, Niederwieser D, Platzbecker U, Schwind S. Jentzsch M, et al. Among authors: schulz j. Blood Cancer J. 2021 Apr 29;11(4):80. doi: 10.1038/s41408-021-00471-x. Blood Cancer J. 2021. PMID: 33927190 Free PMC article. No abstract available.
1,884 results